HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS-INFECTED RHESUS-MONKEYS

被引:25
作者
VOSS, G
LI, J
MANSON, K
WYAND, M
SODROSKI, J
LETVIN, NL
机构
[1] DANA FARBER CANC INST,HUMAN RETROVIROL LAB,BOSTON,MA 02115
[2] TSI MASON LABS,WORCESTER,MA 01608
关键词
D O I
10.1006/viro.1995.1209
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Because of the importance of the envelope glycoprotein (Env) in determining the pathogenicity of HIV-1 and the importance of the immune response to Env in controlling virus spread, attempts are being made to study HIV-1 Env-directed immunity in primate models. To date HIV-1 Env-specific effector T lymphocyte responses have not been demonstrated in virus-infected nonhuman primates. We have previously reported that cynomolgus monkeys can develop a persistent infection with a chimeric simian-human immunodeficiency virus (SHIV) composed of SIVmac239 carrying the HIV-1 env, tat, rev, and vpu genes. We now demonstrate that SHIV-infection of another macaque species, the rhesus monkey, generates persistent, HIV-1 Env-specific cytolytic T lymphocyte (CTL) responses. These CTL are CD8(+) and major histocompatibility complex (MHC) class I-restricted. The induction of CTL was correlated neither to the virus load nor to the MHC class I haplotypes of the monkeys. The SHIV-infected rhesus monkey can, therefore, now be employed for studying effector T lymphocyte recognition of HIV-1 Env. (C) 1995 Academic Press, Inc.
引用
收藏
页码:770 / 775
页数:6
相关论文
共 22 条
  • [1] Agy M.B., Frumkin K.R., Corey L., Coombs M., Wolinsky S.M., Koehler J., Morton W.R., Katze M.G., Infection of Macaca nemestrina by human immunodeficiency virus type-1, Science, 257, pp. 103-106, (1992)
  • [2] Berman P., Gregory T., Riddle L., Nakamura G., Champe M., Porter J., Wurm F., Hershberg R., Cobb E.K., Eichberg J., Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160, Nature, 345, pp. 622-625, (1990)
  • [3] Brodsky F.M., Parham P., Monomorphic anti-HLA-A, B, C monoclonal antibodies detecting molecular subunits and combinatorial determinants, J. Immunol, 128, pp. 129-135, (1982)
  • [4] Cheng-Mayer C., Quiroga M., Tung J.W., Dina D., Levy J.A., Viral determinants of human immunodeficiency virus type 1 T-ceil or macrophage tropism, cytopathogenicity and CD4 antigen modulation, J. Virol, 64, pp. 4390-4398, (1990)
  • [5] Emini E.A., Schleif W.A., Nunberg J.H., Conley A.J., Eda Y., Toki-Yoshi S., Putney S.D., Matsushita S., Cobb K.E., Iett C.M., Eichberg J.W., Murthy K.K., Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody, Nature, 355, pp. 728-730, (1992)
  • [6] Fultz P.N., McClure H.M., Swenson R.B., McGrath C.R., Brodie A., Getchell J.P., Jensen F.C., Erson D.C., Broderson J.R., Francis D.P., Persistent infection of chimpanzees with human T'lymphotropic virus type lll/lymphadenopathy-associated virus: A potential model for acquired immunodeficiency syndrome, i, Virol, 58, pp. 116-124, (1986)
  • [7] Girard M., Kieny M.P., Pinter A., Barre-Sinoussi F., Nara P., Kolbe H., Kusumi K., Chaput A., Reinhart T., Muchmore E., Ronco J., Kaczorek M., Gomard E., Gluckman J.C., Fultz P.N., Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus, Proc. Natl. Acad. Set. USA, 88, pp. 542-546, (1991)
  • [8] Gotch F.M., Kelly C., Ellis S.A., Wallace F., Rickinson A.B., Van Der Poel J., Crumpton M.J., McMichael A.J., Characterization of the FU A2.2 subtype. T cell evidence for further heterogeneity, Immunogenetics, 21, pp. 11-23, (1985)
  • [9] Hirsch V.M., Martin J.E., Dapolito G., Elkins W.R., London W.T., Goldstein S., Johnson P., Spontaneous substitutions in the vicinity of the "V3 analog" affect cell tropism and pathogenicity of simian immunodeficiency virus, J. Virol, 68, pp. 2649-2661, (1994)
  • [10] Javaherian K., Langlois A., Schmidt S., Kaufman M., Cates J., Langedijk N., Meloen R., Desrosiers R., Burns D., Bolognesi D., Larosa G., Putney S., The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus, Proc. Natl. Acad Sci. USA, 89, pp. 1418-1422, (1992)